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Abstract
Background: The mammalian genome is transcribed into large numbers of long noncoding RNAs (lncRNAs), but
the definition of functional lncRNA groups has proven difficult, partly due to their low sequence conservation and
lack of identified shared properties. Here we consider promoter conservation and positional conservation as
indicators of functional commonality.
Results: We identify 665 conserved lncRNA promoters in mouse and human that are preserved in genomic
position relative to orthologous coding genes. These positionally conserved lncRNA genes are primarily associated
with developmental transcription factor loci with which they are coexpressed in a tissue-specific manner. Over half
of positionally conserved RNAs in this set are linked to chromatin organization structures, overlapping binding sites
for the CTCF chromatin organiser and located at chromatin loop anchor points and borders of topologically
associating domains (TADs). We define these RNAs as topological anchor point RNAs (tapRNAs). Characterization of
these noncoding RNAs and their associated coding genes shows that they are functionally connected: they
regulate each other’s expression and influence the metastatic phenotype of cancer cells in vitro in a similar fashion.
Furthermore, we find that tapRNAs contain conserved sequence domains that are enriched in motifs for zinc finger
domain-containing RNA-binding proteins and transcription factors, whose binding sites are found mutated in
cancers.
Conclusions: This work leverages positional conservation to identify lncRNAs with potential importance in genome
organization, development and disease. The evidence that many developmental transcription factors are physically
and functionally connected to lncRNAs represents an exciting stepping-stone to further our understanding of
genome regulation.
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Background
Long noncoding RNAs (lncRNAs) comprise the main
transcriptional output of the mammalian genome, with
recent surveys cataloguing over 100,000 lncRNA genes
in humans [1, 2]. While many of these lncRNAs are
transcribed by RNA polymerase II and are predomin-
antly spliced and polyadenylated in a similar manner to
protein-coding genes, no sequence or structural features
have been identified yet that are predictive of their
biological functions.
The functions of only a small fraction of lncRNAs
have been experimentally tested. A recent screen using
transcriptional CRISPR interference knock-down showed
that expression of hundreds of lncRNAs is essential for
cellular growth, with them playing highly cell type-
specific roles [3]. While lncRNA transcription can influ-
ence the expression of neighbouring genes [4], a number
of studies have shown that lncRNAs themselves have
diverse roles regulating genome function and gene expres-
sion at different levels [5–8]. From a mechanistic point of
view, lncRNAs can act both post-transcriptionally and at
the level of chromatin organization, structure and tran-
scription, where they can affect genes in the immediate
genomic vicinity (in cis) and/or in other genomic locations
(in trans) to repress or promote expression. Well-studied
repressors include lncRNAs associated with imprinted loci
such as AIRN (Antisense IGF2R ncRNA) and KCNQ1OT1
(KCNQ1 opposite strand/antisense transcript 1), which
promote silencing of genomically associated genes in an
allele-specific manner [9]. Examples of activator RNA loci
include the lncRNAs HOTTIP (HOXA transcript at the
distal tip) and transcripts with ‘enhancer-like function’,
such as ncRNA-a, which promote expression of neigh-
bouring genes [10–14].
In contrast to coding genes, most lncRNAs do not
exhibit high levels of primary sequence conservation
across species [1, 15, 16]. In fact, the increasing cata-
logue of characterised lncRNAs, such as AIRN and
XIST (X inactive-specific transcript), indicates that
they evolve under different functional constraints and
exhibit higher evolutionary plasticity [17, 18]. Other
indications as to what some of these differing con-
straints may be include the early observation that
lncRNAs often have promoters that exhibit higher
conservation and that this conservation extends to
longer sequence stretches than observed for pro-
moters of coding genes [15].
lncRNAs with conserved promoters and expressed in
different species have been reported to be associated
with orthologous genes that often have developmental
functions [5, 19–23]. For example, the lncRNA SOX2OT
(SOX2 overlapping transcript) has alternative syntenic
isoforms transcribed from highly conserved promoters
in all vertebrate groups, with similar expression patterns,
particularly in the central nervous system [24].
Importantly, other characterised lncRNAs that fall in
the same category, such as HOTTIP, NeST/INFG-AS1
and Evf2/Dlx6os (Dlx6 opposite strand transcript), and
many imprinted lncRNAs were demonstrated to par-
ticipate in the regulation of the associated genes [12,
25–28]. Moreover, recent transcriptomic and cross-
species analyses have shown that synteny is observed
for hundreds of lncRNAs across the genomes of am-
niotes and beyond [16, 29]. This suggests a functional
association that has been maintained across evolution,
although the functional implications and regulatory
features of this genomic organization are still not well
understood.
Here, we systematically characterise genomic pos-
itional conservation of lncRNAs in mammals and inves-
tigate whether this feature is indicative of their biological
roles. We identify 1700 positionally conserved lncRNAs,
transcribed from 665 conserved syntenic promoters, and
find that they are predominantly associated with
developmental genes, with which they are generally co-
expressed in a conserved tissue-specific manner. Our
analysis identifies a new subgroup of lncRNAs, which
are positioned at topological anchor points (loop end
points and chromatin boundaries). These RNAs, which
we call topological anchor point (tap)RNAs, have con-
served domains and motifs, can regulate the expression
of associated genes and similarly affect cancer-related
phenotypes. This analysis provides a rich resource for
the in-depth characterization of the heterogeneous fam-
ily of lncRNAs and their relationship to chromatin topo-
logical organization.
Results
A promoter-centric approach identifies positionally
conserved RNAs
There is a paucity of information regarding the classifica-
tion of lncRNAs into groups with common functionality.
Here we considered that the conserved position of
lncRNAs relative to coding genes may define a basis for
identifying and characterizing common properties and for
functional indexing. We therefore set out to identify
spliced lncRNAs that are positionally conserved in
mammalian genomes. We compiled a comprehensive
catalogue of human and mouse transcripts based on (1)
Gencode annotation [30, 31]; (2) human and mouse RNA-
sequencing (RNA-Seq) data from six matched tissues
(brain, cerebellum, heart, kidney, liver and testis) [32]; and
(3) RNA-Seq data from four similar human and mouse
cell lines (embryonic stem (ES), leukaemia, lymphoblast
and muscle cells) produced by the ENCODE project
(Additional file 1: Table S1) [33, 34]. In total, we processed
80 RNA-Seq datasets and successfully mapped 2.6 billion
reads.
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Our analysis pipeline is designed for comprehensive
identification of human and mouse transcripts from
both Gencode and the RNA-Seq data, with evidence of
splicing, no overlap with coding exons in the same
transcriptional orientation and no significant coding
potential (Fig. 1a). Promoter sequences of human
lncRNAs were then aligned to the mouse genome to
identify syntenic lncRNAs (Additional file 2: Supplementary
methods) with high promoter conservation. Syntenic
lncRNAs were defined as positionally conserved if their
promoters were genomically associated with orthologous
genes and produced spliced lncRNAs in the same relative
transcriptional orientation (either sense or antisense relative
to the coding gene) in both mouse and human (Additional
file 2: Supplementary methods).
The resulting set of positionally conserved lncRNAs
(pcRNAs) comprises 1700 transcripts, including spli-
cing isoforms, associated with 665 unique conserved
promoters and a total of 626 orthologous coding genes
(Additional file 3: Table S2). The majority of pcRNAs
(82 %, 1401/1700 transcripts, transcribed from 595
independent promoters) were Gencode annotated
human transcripts, while 299 (18 %) represented novel
transcripts assembled from the RNA-Seq data. We
also found that a small number of pcRNAs (138, tran-
scribed from 32 independent promoters) overlapped
syntenic microRNA (miRNA) loci.
We classified pcRNAs into seven categories based on
their genomic orientations relative to the associated cod-
ing genes (Fig. 1b).
The predominant category is bidirectional tran-
scripts (42 % of all pcRNAs), followed by antisense
(18 %), with all other categories similarly represented
(between 5 and 9 %) (Additional file 4: Figure S1a).
On average they are 1.3 kb long (Additional file 4:
Figure S1b), have three to four exons (mean 3.6 exons
per pcRNA; Additional file 4: Figure S1c) and are
proximal to protein-coding genes (Additional file 4:
Figure S1d). Analysis of FANTOM5 data [35] revealed
that the majority of human pcRNAs have transcrip-
tion start sites (TSSs) supported by CAGE tags (9 bp
median distance between TSS and closest CAGE tag;
Additional file 4: Figure S2a), providing further evi-
dence for our identification of pcRNA promoters.
Despite being less conserved than their associated
coding genes, human pcRNAs have on average 31 %
sequence identity with their mouse counterparts
(Additional file 4: Figure S2b) and display conserva-
tion at the intron–exon junctions (Additional file 4:
Figure S2c). Furthermore, inspection of the lncATLAS
database [36], which provides scores for expression of
lncRNAs in subcellular compartments, showed that
pcRNAs are predominantly localised in the nucleus
(Additional file 4: Figure S2d).
Genomic association and conserved co-regulation with
genes encoding developmental transcription factors
Gene Ontology (GO) analysis of the 626 coding genes with
which pcRNAs are associated showed a very strong enrich-
ment for genes with roles in regulation of transcription from
RNA polymerase II promoter (GO:0045944 and GO:0000122,
adjusted p values = 1.2 × 10−15 and 8.5 × 10−10 respectively;
Fig. 1c; Additional file 5: Table S3). These are transcription
factors involved in cell fate determination (GO:0001709, ad-
justed p value = 0.00265) and developmental induction
(GO:0031128, adjusted p value = 0.00265), which are cen-
tral in the determination of a variety of specific devel-
opmental systems and embryonic stages, such as
regulation of gastrulation, stem cell maintenance and
organ morphogenesis (Additional file 5: Table S3).
Notably, many of these genes belong to major gene
families containing regulators of lineage specification,
such as SOX genes (including SOX1, 2, 4, 9 and 21),
FOX genes (FOXA2, D3, E3, F1, I and P4), HOX
genes (e.g. HOXA1, A2, A3, A11, A13, B3, C5 and
D8) and other homeodomain genes, as well as several
nuclear receptors, such as NR2E1, NR2F1 and NR2F2
(Additional file 5: Table S3 and Additional file 6:
Table S4). To verify whether the enrichment observed
for pcRNAs could indirectly result from the preferen-
tial location of developmental genes in gene-sparse
regions, we repeated the GO enrichment analysis
controlling for the size of the intergenic region sur-
rounding pcRNA-associated coding genes and con-
firmed a significant enrichment for developmental
terms (Additional file 2: Supplementary methods and
Additional file 4: Figure S2e).
To quantify the expression of pcRNAs and their asso-
ciated protein-coding genes, we used publicly available
RNA-Seq data (Additional file 1: Table S1), as well as a
custom code set for the Nanostring expression assay that
probed approximately 50 human and mouse manually
selected pcRNAs and associated orthologous protein-
coding genes (Additional file 2: Supplementary methods)
across a broad panel of RNA from human and mouse
tissues and cell lines (Additional file 7: Table S5).
Both RNA-Seq and Nanostring data showed that
pcRNAs have significantly conserved expression patterns
across mouse and human tissues (mean Spearman’s
correlation 0.26, p value < 10−6; Additional file 4:
Figure S3a–d) and their expression is positively corre-
lated with the associated coding genes (mean Spear-
man’s correlation 0.25, p value < 10−6; Fig. 2a;
Additional file 4: Figure S3e). Furthermore, the dis-
tance between a pcRNA and the corresponding cod-
ing gene has a negligible effect on their correlation of
expression, indicating that co-expression is not merely
a consequence of their proximity (R2 = 0.008, p value
= 3.23 × 10−4; Additional file 4: Figure S3f ).
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We found that pcRNAs display a tissue-specific
expression profile and have significantly higher tissue
specificity than their associated coding genes (Additional
file 4: Figure S4a–d), also when correcting for their
lower expression level (Additional file 4: Figure S4e, f ).
Tissue-specific pcRNAs tend to be genomically associ-
ated with coding genes involved in developmental and
differentiation processes relevant to that particular tis-
sue, such as neural differentiation genes for brain-
specific pcRNAs and endoderm developmental genes for
liver-specific pcRNAs (Additional file 4: Figure S5a–d).
We validated the tissue expression and temporal co-in-
duction for a number of coding–non-coding pairs by
qPCR (Additional file 4: Figure S6). Taken together,
these data suggest that pcRNAs and their corre-
sponding coding genes are often co-regulated in
mouse and human.
The Nanostring data also revealed that pcRNAs often
form clusters of co-expression with several functionally re-
lated regulatory genes (Additional file 4: Figure S7a, b). For
instance, two connected clusters are comprised of tran-
scription factors that are master regulators of endoder-
m—in particular liver cell differentiation (HNF1A, FOXA2/
HNF3B and HNF4A) [37, 38]—and associated pcRNAs. For
example, FOXA2 and its associated pcRNA FOXA2-DS-S
exhibit very similar expression profiles across tissues in
both human and mouse (Fig. 2b), and similar results are
observed for HNF1A and its pcRNA HNF1A-BT1/2
(Additional file 4: Figure S8a). These expression data sug-
gest that pcRNAs share upstream regulatory elements with
neighbouring protein-coding genes and/or have a role in
their regulation.
Identification of tapRNAs
To investigate the principles of pcRNA regulation, we
first inspected chromatin modification profiles around
their TSSs. Using the ENCODE genome-wide datasets
for different human cell lines (ENCODE tier 1 lines
GM12878, H1-hESCs, HSMM and K562) [33, 39], we
detected a clear enrichment in H3K4 di- and tri-
methylation (H3K4me2/3) and H3K9 and H3K27 acetyl-
ation (H3K9ac, H3K27ac) (Additional file 4: Figure S9),
as well as H3K27 tri-methylation (H3K27me3) and
bivalent marks specifically for pcRNA promoters in em-
bryonic stem (ES) cells (Additional file 4: Figure S10).
These profiles are indicative of RNA polymerase II
promoters, similar to those observed for protein-coding
genes (Additional file 4: Figure S9). Interrogation of the
FANTOM5 Consortium database [35], containing com-
prehensive annotations of over 40,000 enhancer regions,
identified the promoters of only three pcRNAs as en-
hancers (associated with GATA2, HES1 and KLF4; data
not shown).
Using chromatin immunoprecipitation sequencing (ChIP-
Seq) peaks for transcription factors obtained by the
ENCODE project [33, 40], we observed a highly concordant
pattern of occupancy in the promoters of pcRNAs and asso-
ciated genes (Pearson correlation coefficient = 0.67, p value
< 1 × 10−3; Fig. 2c). Such general co-regulation was further
supported by the analysis of predicted transcription factor
binding motifs in both promoters (Pearson correlation coeffi-
cient = 0.63, p value < 1 × 10−3; Fig. 2d). Surprisingly, we
found evidence of binding for CCCTC-binding factor
(CTCF) throughout pcRNA loci (Fig. 2c), but strongly
enriched in the regions adjacent to the TSSs of most
pcRNAs: 72 % of pcRNA promoters contain a CTCF peak
and a significant enrichment is seen with respect to other
spliced lncRNAs and protein-coding genes (Fig. 3a).
Since topological organization of chromatin is dictated
to a large extent by CTCF binding [41, 42], we interro-
gated high resolution, genome-wide topological maps [43]
to establish the positioning of pcRNAs and their coding
genes relative to genomic loops. We found that pcRNAs
are preferentially located at the boundaries of topologically
associating domains (TADs) and chromatin loops (Fig. 3b,
c). In particular, we noticed that a remarkable proportion
of pcRNAs (912 out of 1700 pcRNAs isoforms, 54 %) have
a promoter within 10 kb of a TAD boundary (446
pcRNAs) and/or directly intersecting a loop anchor point
(764 pcRNAs; Fig. 3d). For example, the HOXD cluster is
embedded in a region with high density of CTCF peaks,
located at the edge of TADs with different syntenic
lncRNAs in their boundaries, including Hog and Tog
(Hotdog and Twin-of-hotdog) [44] (Fig. 3e). Similarly, the
pcRNA TBX2-BT and other pcRNAs associated with
important developmental genes lie at TAD boundaries
and overlap multiple loop anchor points (Additional file 4:
Figure S11).
The proportion of pcRNA promoters that overlap a
loop anchor point or a TAD boundary is significantly
higher than that of Gencode spliced lncRNAs (p value =
3.4 × 10−23; Fig. 3f; Additional file 4: Figure S12a–c). In
(See figure on previous page.)
Fig. 1 Identification of pcRNAs and tapRNAs. a Workflow used for the identification of pcRNAs and tapRNAs. b The possible orientations of a
pcRNA (red) relative to a coding gene (blue). c Gene Ontology (GO) enrichment analysis of pcRNA-associated coding genes. The x-axis shows the
enrichment score, calculated as the number of pcRNA-associated genes in a given GO category divided by the total number of genes in the
category. The size of the points indicates the absolute number of pcRNA-associated genes in the given GO category. The colour-coding indicates
the adjusted p value. CDS coding sequence
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addition, the promoters of pcRNA-associated protein-
coding genes are enriched in TAD boundaries or loop
anchor points compared to other coding genes, al-
though to a lesser extent than pcRNAs themselves
(Fig. 3f; Additional file 4: Figure S12a, b).
Interestingly, we found that the location where loop an-
chor points are positioned around and within pcRNAs
peaks distinctively at their TSSs (Fig. 3f). This is observed
for pcRNAs with promoters located proximally and dis-
tally relative to the promoters of associated genes (Add-
itional file 4: Figure S12b, c) and is consistent with the
observed positioning of CTCF binding sites at the TSSs
(Fig. 3a), indicating that the transcription of several
pcRNAs starts at the base of topological loops in precise
correspondence with CTCF anchors (Fig. 3a–c). Given
this marked and precise association of pcRNA promoters
with loop anchor points, we defined this group of 764
pcRNAs as ‘topological anchor point RNAs’ (tapRNAs),
representing the subset of pcRNAs whose promoters over-
lap a loop anchor point (Fig. 3d).
Based on the chromatin state segmentation by
HMM from ENCODE/Broad for nine cell lines [45],
we found that the contacting loop anchor points are
marked by multiple chromatin states and that a high
proportion overlaps marks of active transcription and/
or enhancers (Additional file 4: Figure S12d). tap-
RNAs are significantly more likely to be in contact
with enhancer elements through such loops, com-
pared to Gencode lncRNAs (p value = 2.85 × 10−6;
Fig. 3g). This is not the case for the contact with
promoter elements, transcribed regions or other
HMM-defined genomic regions (Fig. 3g; Additional
file 4: Figure S12e). These results indicate that tap-
RNAs are likely to be associated with enhancer se-
quences present on the other end of the loop.
Moreover, inspection of ChIP-Seq data showed binding of
several factors associated with looping and regulatory
elements on both sides of the majority (> 90 %) of the tap-
RNA loops (Additional file 4: Figure S13a), including RNA
polymerase II, p300, C/EBP, EZH2 and zinc finger proteins
such as Znf143 (see e.g. [42, 46, 47]).
Conserved domains and motifs in tapRNAs
We found that tapRNAs display higher sequence conserva-
tion across vertebrate genomes compared to generic Gen-
code lncRNAs, although this conservation is lower than
that observed for protein-coding genes (Fig. 4a). This obser-
vation led us to further investigate whether there is any
similarity of sequence that may provide clues to the func-
tion of tapRNAs. To this end, we applied a sliding-window
direct RNA alignment approach, finding that 73 % of tap-
RNAs show high conservation in patches of sequence be-
tween human and mouse (Additional file 2: Supplementary
methods), while the other 27 % lack these highly conserved
patches (Fig. 4b). We divided the conserved 73 % into (a)
high-, (b) medium-, and (c) low-conservation-region tap-
RNAs and carried out a GO enrichment analysis on their
associated coding genes. In all cases, the predominant
category of genes associated with conserved tapRNAs was
linked to development. In contrast, the 27 % of tapRNAs
with no highly conserved segments (d) were associated with
genes showing no strong enrichment in functional categor-
ies. These data suggest that tapRNAs associated with devel-
opmental transcription factor genes have more significant
sequence conservation than other tapRNAs.
The fact that we can detect discrete conserved se-
quence domains within the tapRNA group (Fig. 4b, c)
prompted us to examine whether there are any sequence
motifs in common between them. Motif enrichment
analysis identified 32 8-mer motifs that were signifi-
cantly more represented in the conserved domains of
tapRNAs relative to non-conserved sequences (Fig. 4d;
Additional file 4: Figure S13b). Closer inspection indi-
cated that these 32 motifs were related and could be
sub-categorised into ten consensus motifs. Analysis of
the JASPAR database [48] of consensus sequences recog-
nised by known RNA binding proteins (RBPs) found that
each of the ten motifs has the potential to bind RBPs, in-
cluding proteins involved in RNA metabolism and regu-
lation (such as hnRNP A2/B1 and hnRNP K, HuR,
ELAV and EGR1), with the predominant type (seven out
of ten motifs) corresponding to binding motifs of RBPs
containing different zinc finger (ZF) domains (Fig. 4d).
(See figure on previous page.)
Fig. 2 pcRNA expression and regulation. a Density distribution of the Spearman’s correlation coefficients between pcRNAs and corresponding
coding genes in human tissues and cell lines (mean Spearman’s rho 0.25, permutation test p value < 10−6). The dotted line shows the background
distribution of all pairwise Spearman’s correlations between pcRNAs and pcRNA-associated coding genes. Inset: Distributions of the Spearman’s
correlation coefficients divided by the positional category of the pcRNA. AS antisense, BT bidirectional, DS-AS downstream antisense, DS-S
downstream sense, OLAP overlapping, US-AS upstream antisense, US-S upstream sense. b Nanostring expression profiles of FOXA2 and FOXA-DS-S
across human (top) and mouse (bottom) tissues. The points indicate the mean value of two technical replicates, while the vertical bars report the
value of each replicate. c Transcription factor binding patterns in the promoters of pcRNAs (middle), their associated coding genes (left), and
across pcRNA loci (right). The heatmaps present the distribution of experimentally validated TF-binding sites from 2216 ENCODE ChIP-Seq experiments
(y-axis), showing a high degree of co-occupancy between the promoters of pcRNAs (x-axis) and their associated coding genes. The blue bar graph on
top of each heatmap shows correlation (r values) between a pcRNA and its associate coding gene. The color bars next to the right heatmap indi-
cate the TF groups showing dominant binding patterns. d Same as in c but indicating the presence of TF-binding motifs based on known motifs
annotated in JASPAR (freeze 2014–12–10, 263 motifs), in Kheradpour and Kellis [100] (2065 motifs) and in Jolma et al. [101] (843 motifs)
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This indicates that conserved sequences within tapRNAs
may represent RNA binding motifs that regulate their
processing and function. Furthermore, we found that the
ten consensus motifs also match the binding motifs of
known transcription factors, including a large number of
ZF factors, such as CTCF, ZIC2 and ZNF263 (Additional
file 4: Figure S13c). This association raises the possibility
that some of the RNA aligned stretches between mouse
and human tapRNAs might reflect an overlap to con-
served transcription factor binding sites in the under-
lying DNA sequence, although the functional relevance
remains to be determined (see “Discussion”).
tapRNAs regulate neighbouring genes
Given that tapRNAs and their neighbouring genes are
co-expressed in a tissue-specific manner, we investigated
their ability to regulate each other’s expression. First, we
tested this hypothesis on a key liver master regulator,
FOXA2, and its associated tapRNA. ChIP-Seq data [49,
50] show that the promoters of the FOXA2 gene and
FOXA2-DS-S are occupied by a similar set of transcrip-
tion factors, and importantly, the same key regulators of
liver differentiation (FOXA1, FOXA2, HNF4A and HNF6;
Fig. 5a; Additional file 4: Figure S14). This again suggests
that the mechanism of co-expression and co-induction
is due, at least in part, to specific factors concomitantly
regulating expression of both the coding and noncoding
transcripts.
We next investigated whether FOXA2-DS-S can affect
the expression of the associated coding gene, finding that
FOXA2-DS-S is necessary for full expression of the
FOXA2 gene (Fig. 5b; Additional file 4: Figure S15a), since
its down-regulation by RNA interference results in
reduction of FOXA2 expression in Huh7 liver cancer cells
(Fig. 5b) and A549 lung cancer cells (Additional file 4:
Figure S15a). Interestingly, knock-down of FOXA2 also
leads to down-regulation of FOXA2-DS-S (Fig. 5b;
Additional file 4: Figure S15a). These results indicate that
FOXA2 not only auto-regulates by binding its own pro-
moter (Additional file 4: Figure S14), but also affects the
expression of the associated tapRNA, providing a positive
feedback loop and suggesting interdependence.
Microarray analysis of the global transcriptional
effects of FOXA2-DS-S or FOXA2 knock-down showed
a large overlap in the repertoire of affected genes (Fig.
5c, d). This suggests that the major target for FOXA2-
DS-S is the FOXA2 gene, although additional direct tar-
gets may yet be identified. These findings were recently
independently supported by the cis-regulation of
FOXA2 in differentiating definitive endoderm cells by
FOXA2-DS-S (also known as DEANR1, or ‘definitive
endoderm-associated lncRNA1’), indicating that this
lncRNA regulates FOXA2 in different endoderm-
derived tissues [51].
We obtained similar results for a tapRNA associated
with a second liver factor, HNF1A, and five other tested
tapRNAs in different cell lines (FOXD2-AS, SETD1B-BT,
POU3F3-BT and NR2F1-BT; Additional file 4: Figure S8
and S15a–d). These were chosen among tapRNAs
specifically co-expressed with the associated genes in
different tissues and cell types, and in each of these
cases, knock-down of the tapRNA reduces expression of
the associated coding gene. Interestingly, knock-down of
HNF1A-BT1 reduces expression of HNF1A (Additional
file 4: Figure S8a) but ectopic over-expression of full-
length HNF1A-BT in human liver cells had no effect on
the associated gene, even though very high levels of
over-expression were achieved (data not shown), again
suggesting a cis-based context-dependent mode of regu-
lation. Although the functional association with chroma-
tin looping needs to be systematically tested (see
“Discussion”), we posit that novel tapRNAs co-expressed
(See figure on previous page.)
Fig. 3 Identification of tapRNAs. a The proportion of pcRNAs, pcRNA-associated coding genes, Gencode lncRNAs and Gencode coding genes
with a CTCF peak (based on Encode ChIP-Seq data) overlapping their promoter. The p values reported were calculated with hypergeometric tests.
Right: CTCF peak coverage of loci of pcRNAs, pcRNA-associated coding genes, Gencode lncRNAs and Gencode coding genes. The plots report
the loci from 20 kb upstream of the transcription start site (TSS) to 20 kb downstream of the transcription end site (TES). For visualization purposes
these profiles show the coverage of a random sample of 5000 Gencode lncRNAs and 5000 random Gencode coding genes. b, c Aggregation
density plots showing the distribution of the TSS of pcRNAs (red) and lncRNAs (orange) relative to chromatin topological domains (b) and
chromatin loop anchor points (c). Domains and loop anchor points were defined based on HiC data. d Venn diagram showing the number of
pcRNAs whose promoters overlap a loop anchor point (purple) or a domain boundary (green). e The HOXD locus showing the tapRNAs and chro-
matin loops defined by HiC data [43]. Modified from a screenshot of the UCSC genome browser. f The proportion of pcRNAs, pcRNA-associated
coding genes, Gencode lncRNAs and Gencode coding genes with a HiC loop overlapping their promoter. The p values reported were calculated
with hypergeometric tests. Right: HiC loop coverage of loci of pcRNAs, pcRNA-associated coding genes, Gencode lncRNAs and Gencode coding
genes. The plotted genomic regions encompass the loci from 20 kb upstream of the TSS to 20 kb downstream of the TES. For visualization
purposes these profiles show the coverage of a random sample of 5000 Gencode lncRNAs and 5000 random Gencode coding genes. g Cumulative
distribution plot showing the percentage of distal genomic regions in contact with pcRNA promoters (y-axis) as a function of the fraction of length of
loop-end annotated as enhancer (left) or promoter (right). For example, the “≥ 0.4” point (x-axis) of the red line in the first plot indicates that ~ 37 %
(y-axis) of the distal genomic regions in contact with pcRNA promoters are annotated as enhancer for 40 % or more of their length. Promoters of
pcRNAs are significantly more often in contact through loops with enhancer elements compared to generic Gencode lncRNAs (p value 2.85 × 10−6).
The indicated p values were calculated using the Kolmogorov-Smirnov test
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with their associated genes in mouse and humans are
strong candidates for cis-regulators with important cellu-
lar roles. For instance, a recent large-scale phenotypic
screen by CRISPR-interference has identified numerous
lncRNAs essential for cellular growth [3]. This set was
enriched for pcRNAs and tapRNAs (highlighted in
Additional file 3: Table S2; p values = 1.14 × 10−26 and
6.51 × 10−13, respectively) and included numerous anti-
sense and bidirectional tapRNAs (respectively, 28 and 40
tapRNAs), such as FOXD3-BT and NKX1–2-AS, as well
as more distal ones (25 tapRNAs), such as SOX4-DS-S
and MTX2-DS-AS (TOG) (Additional file 3: Table S2).
tapRNAs are implicated in cancer
The Nanostring analysis of the cancer cell panel also
demonstrated specific expression of pcRNAs, including
many of the tapRNAs and associated genes, in differ-
ent cancer lines (Additional file 4: Figure S16a–e).
lncRNAs are already considered important players in
disease [1, 52, 53] and many genes with roles in
development have been previously linked to cancer
and other disorders [54]. We therefore investigated
the possible involvement of different pcRNAs in
cancer cells. To explore this association, we per-
formed a meta-analysis of the expression of pcRNAs
in normal versus tumour samples in 63 microarray
studies. After re-annotating the microarrays to iden-
tify probes targeting pcRNAs, we identified 203
pcRNAs significantly differentially expressed in tu-
mours compared to normal tissues (Additional file 4:
Figure S17a and Additional file 8: Table S6). These in-
cluded known cases of lncRNAs involved in different can-
cers, such as GAS5, DLEU2, PART1 and MEG3. We
expanded this analysis to The Cancer Genome Atlas
(TCGA) RNA-Seq data available for 24 different cancer
types and over nine thousand samples [55] and verified
that 443 pcRNAs were annotated and differentially
expressed in this dataset (Additional file 4: Figure S17b).
Among these, we catalogued the 203 tapRNAs that are
differentially expressed in tumours compared to normal
tissues, forming clusters of expression that clearly distin-
guish cancer types (Additional file 5: Figure S18a and
Additional file 3: Table S2).
tapRNA expression in different cancers is largely mir-
rored by the expression of the associated coding genes
(Additional file 4: Figure S18a, b), consistent with the
positive correlation observed in normal tissues. Repre-
sentation of the correlation of expression between tap-
RNAs and associated genes (p value = 1.13 × 10−11)
showed marked positive correlation signatures, which
contain several tapRNA–gene pairs with altered expres-
sion in different cancer types (Fig. 6a; Additional file 3:
Table S2). Close inspection of individual tapRNA–gene
pairs with altered expression in primary tumours showed
that a number of them are consistently down- or up-reg-
ulated in cancer compared to normal tissues (Additional
file 8: Table S6). For example, FOXA2 and its tapRNA
FOXA2-DS-S were found significantly down-regulated in
lung tumour compared to normal samples (p values = 3
× 10−16 and 2 × 10−22, respectively), effectively separat-
ing tumour samples from controls (Fig. 6b).
To investigate whether FOXA2-DS-S tapRNA has a
functional effect in cancer, we knocked it down in Huh7
and A549 cells (Fig. 5b; Additional file 4: Figure S15a). A
dramatic increase in both cell invasion and migration
capacity was observed, supporting a tumour suppressor
function for FOXA2-DS-S transcripts similar to the
reported role of FOXA2 in cancer cells [56, 57] (Fig. 6c;
Additional file 4: Figure S15e). These data further support
the close functional link between the tapRNA and its asso-
ciated gene. The fact that FOXA2-DS-S has the same
effect on the phenotypic characteristics of cancer cells as
its associated gene is consistent with its positive effect on
the expression of FOXA2 and the observation that it regu-
lates a similar cohort of genes (Fig. 5c, d). We also ana-
lyzed the role of two other tapRNA–gene pairs in invasion
and migration characteristics of the cancer cells in which
they are expressed (Additional file 4: Figures S16 and
S17a). We found that knock-down of NR2F1-BT and
NR2F1 or POU3F3-BT and POU3F3 similarly reduced the
(See figure on previous page.)
Fig. 4 Conserved sequence motifs in tapRNAs. a Comparison of conservation between tapRNAs, lncRNAs and protein coding genes. The curves
are kernel density estimation (KDE) of conservation scores calculated from the phastCons multiple alignments of 100 vertebrate species. b
Clustered heatmap of conserved domains in transcribed tapRNAs. Aligned sequences (shown in red) in 279 non-redundant tapRNA isoforms are
clustered (Euclidean distance). Sixteen minor clusters were identified and grouped into four major clusters. Each minor cluster’s centroids are
shown with the number of tapRNAs belonging to each minor cluster. Thirty-nine tapRNAs (top group, blue) have a more than ~ 73 % conserved
domain in their transcribed sequences. Functional category annotation search reveals that tapRNAs of the top group are highly related to devel-
opmental proteins or Homeobox proteins. In contrast, 76 tapRNAs of the bottom cluster (grey) do not have any sequence conservation and do
not show significant common functionality. There are also some minor groups in which position-specific conservation is clearly present (e.g. 5′
end-specific or 3′ end-specific). c Example of conserved domains in a tapRNA. RNA sequence alignments of regions conserved between human
and mouse HNF6-US-S tapRNA are represented in red. d Enriched RNA-binding motif in conserved domains of tapRNAs. Thirty-two significantly
enriched 8-mer motifs (Additional file 2: Figure S13b; p value 1 × 10−4) in conserved domains in tapRNAs are identified and clustered into ten
consensus motifs. De novo motif analysis discovers known RNA-binding proteins (RBPs) with matching binding consensus motifs. Seven out of
ten consensus motifs are part of binding motifs of zinc finger proteins
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invasion/migration potential of U251MG glioblastoma and
U2OS osteosarcoma cells (Additional file 4: Figure S15f–h).
Thus, in the case of NR2F1-BT and POU3F3-BT, their effect
on cell invasion/migration suggests that tapRNAs may also
have oncogenic roles in these cells, likely involving the regu-
lation of the associated genes.
Finally, considering the recent involvement of CTCF
and architectural mutations in activation of oncogenes
in specific tumours [58, 59], which represent hitherto
overlooked potential causative mutations, we performed
a mutational analysis of CTCF motifs associated with
tapRNA loci. We observed a significantly more frequent
mutation of CTCF sites in tapRNA promoters and tran-
scribed regions compared to Gencode lncRNAs (p value
= 1.63 × 10−12; Fig. 6d). Given our finding that binding
sites for additional zinc finger motif transcription factors
are enriched in tapRNA conserved sequences (Additional
file 4: Figure S13c), we asked if mutations in cancer are
also present in ZNF263 sites, which was among the highly
enriched motifs associated with tapRNAs and for which
there is available ChIP-Seq data (Fig. 3e; Additional file 4:
Figure S13c). Indeed, we observed an even more marked
enrichment for mutations in ZNF263 sites in cancers than
CTCF (p value = 7.58 × 10−14; Fig. 6d).
We investigated whether there was a connection be-
tween these mutations and the expression of tapRNAs,
using matched tissues for TCGA expression data and
cancer mutation. We found evidence that for 25 tap-
RNAs the mutation of CTCF (19 tapRNAs) or ZNF263
(7 tapRNAs) coincides with a significant change in
tapRNA expression in the equivalent cancer (Additional
file 9: Table S7). These included 16 mutated sites with
ChIP-sequencing evidence for CTCF/ZNF263 binding,
indicating that the mutation may interfere with TF bind-
ing and regulatory activity, and encompassed cis-acting
lncRNAs previously implicated in cancer, such as
HOTAIRM1 (HOXA1-AS) [60], HOTTIP (HOXA13-BT)
[61], ZEB1-AS [62] and ZEB2-AS [63, 64]. For example,
mutations in ZNF263 binding sites are found in the
promoter of ZEB2-AS/ZEB2, associated with altered ex-
pression of both the tapRNA and ZEB2, which is a
master-regulator of epithelial-to-mesenchymal transition
(EMT) and metastasis [65, 66] (Fig. 6e, f ). This raises
the possibility that, in addition to CTCF binding sites,
mutations in ZNF263 and other motifs associated
with tapRNAs may be involved in cancer. Taken to-
gether these data highlight the fact that tapRNAs can
be considered as potential targets for cancer and that
their expression pattern may act as a marker for the
disease.
Discussion
Syntenic lncRNAs with promoter conservation linked to
developmental genes
In this work, we systematically identify, on a genome-
wide scale, lncRNAs with conserved promoters in
mouse and human, cataloguing 665 lncRNA pro-
moters that are genomically linked to 626 coding
genes. This analysis has identified a subset of position-
ally conserved lncRNAs with a close relationship to a
very specific cohort of neighbouring protein-coding
genes, predominantly comprised of transcription fac-
tors. Our analysis indicates that positionally conserved
lncRNAs and their associated developmental tran-
scription factors have some common characteristics:
they are (a) expressed in the same restricted tissues in
mouse and human and (b) co-induced when cells are
stimulated with a differentiation signal, (c) have pro-
moters bound by similar transcription factors and (d)
can affect each other’s expression.
Consistent with our findings, many lncRNAs defined
here as tapRNAs have been shown to regulate develop-
mental genes in a manner implying local regulation.
These include HOTTIP (HOXA13-AS), HOTAIRM1
(HOXA1-AS), HAGLR (HOXD1-AS), NKX2–1-AS and
DEANR1 (FOXA2-DS-S) [12, 22, 53, 67]. TapRNAs may
add to a growing list of lncRNAs that regulate neigh-
bouring genes in cis, via the RNAs themselves and/or
their act of transcription [4, 13, 14].
We have annotated pcRNAs using a systematic no-
menclature that reflects the conserved orientation of the
pcRNA relative to the neighbouring coding gene. We be-
lieve that this catalogue will be a valuable resource in
the characterization of these important coding genes
and their associated noncoding RNAs.
(See figure on previous page.)
Fig. 5 FOXA2-DS-S regulates FOXA2 expression. a Screenshot from the Dalliance genome browser [50] showing the FOXA2 locus with tracks
displaying coverage data for ChIP-Seq experiments for Pol2, FOXA1, FOXA2, HNF4A, HNF6 and CEBPA. The ChIP-Seq tracks were produced by the
ENCODE project on HepG2 cells. b Real time PCR data showing the expression of FOXA2 and FOXA2-DS-S in Huh7 cells upon knock-down. Si1
and si2 FOXA2-DS-S indicate two different, non-overlapping siRNAs designed against FOXA2-DS-S. The data are expressed relative to the
expression of the control transfected with scrambled siRNAs; the error bars indicate the standard error of the mean across three replicate
experiments. c Venn diagram showing the number of significantly differentially expressed genes (adjusted p value < 0.05 and log2 fold change
> or < 1.25) in the microarray experiment on Huh7 knock-down of FOXA2 or FOXA-DS-S. d Heatmap showing microarray data upon knock-down
of FOXA2 or FOXA-DS-S in Huh7 cells. The colour scale indicates normalised intensities (z-score). The heatmap contains all genes that were
significantly altered (adjusted p < 0.05) upon knoc- down of either FOXA2 or FOXA-DS-S. The scatter plots in the lower part of the panel show GO
enrichment data for genes that were significantly down-regulated (left) or up-regulated (right) in either siFOXA2 or siFOXA-DS-S
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tapRNAs
The most striking feature of pcRNAs is their enrich-
ment in tapRNAs, defined as RNAs found at chro-
matin loop anchor points and at boundaries of
topological domains. These architectural landmarks
are commonly occupied by the CTCF factor and in-
deed we find an enrichment of CTCF binding in the
promoters of tapRNAs and within their conserved
domains. The precise number of tapRNAs within the
cohort of pcRNAs depends on certain definition cri-
teria. We have taken a conservative approach and
defined tapRNAs as those that have their promoters
directly overlapping loop anchor points. If we con-
sider those overlapping either an anchor point or a
TAD boundary we instead identify 54 % (912) of
pcRNA transcripts as tapRNAs, but more relaxed
definitions of pcRNAs (for example including non-
spliced transcripts or pcRNAs that are more clade-
restricted and have lower promoter conservation) as
well as high-resolution HiC data from a broader set
of tissues and developmental stages will likely in-
crease this figure.
tapRNAs have specific features that allow them to be
defined as a distinct group of lncRNA: they (a) overlap
topological anchor points, (b) have the architectural zinc
finger protein CTCF bound within their promoter at
much higher levels than other lncRNAs, and (c) have
conserved domains within the transcripts that are
enriched in consensus binding sites for zinc finger RBPs.
Below we discuss these features associated with tap-
RNAs and how they may relate to the regulation of the
associated developmental genes.
tapRNAs and chromatin looping
The genome is highly structured and gene expression influ-
ences and is influenced by the topological organization of
the chromatin [42, 43, 68–71] (see [42] for review). The
causality of the association of lncRNA and transcription
with chromatin topology is a matter of current investigation
[72, 73]. Likewise, the extent to which the common
properties of tapRNAs reflect the overlap with genomic fea-
tures associated with conserved developmental loci is un-
known. Nevertheless, lncRNAs are emerging as important
actors in the regulation of nuclear architecture [7, 43, 68,
69] and several characterised lncRNAs, defined here as tap-
RNAs, have been implicated in chromatin looping and, in
some of these cases, the regulation of neighbouring genes.
These include several HOX loci-associated RNAs such as
HoxBlinc, HOTTIP, EVX1AS and HOTAIRM1 [12, 20, 74–
77]. These reports provide experimental evidence that tap-
RNAs may be commonly implicated in regulating genes by
affecting topological conformations. These may involve dif-
ferent roles for spliced or non-spliced isoforms of tapRNAs,
as recently demonstrated for HOTAIRM1 in the regulation
of the immediate neighbouring genes and other HOXA
genes within the looping region in differentiating NT2 cells
[76]. Moreover, transcription of lncRNA loci associated
with developmental genes can dictate nuclear
compartmentalization and direct looping between associ-
ated enhancers and gene promoters. This has been recently
demonstrated for the ThymoD (thymocyte differentiation
factor) lncRNA, which regulates the neighboring Bcl11b
gene by modulation of CTCF binding and cohesin-
dependent looping in T-cell fate specification [78].
Further indications of such topological connections
come from many other uncharacterised tapRNAs.
These also include tapRNAs within the HOXD clus-
ter, whose TAD boundaries and chromatin loops are
specifically regulated during embryonic development,
and are associated with differential HOX gene ex-
pression [44, 71, 79]. These boundaries are marked
by syntenic lncRNAs such as HOG and TOG [44],
but also additional non-annotated tapRNAs (Fig. 3e).
Other important genes involved in cell-fate deter-
mination, such as FOXA2 and PDX1, also have pos-
itionally conserved lncRNAs associated with their
TAD boundaries [80, 81].
These data indicate that regulation of chromatin
organization and of expression of developmental genes
may be a common property of tapRNAs in mammals.
(See figure on previous page.)
Fig. 6 pcRNAs are differentially expressed in cancer. a Spearman’s rank-order correlation heatmap between tapRNAs and their associated coding
genes in TCGA RNA-Seq V2 level 3 data. The correlation was calculated between the two matrices of TCGA RNA-Seq fold changes (Additional file
2: Figure S18a, b) and shows that the expression of pcRNAs and corresponding coding genes is correlated within specific cancers. b Spearman
correlation between the expression of FOXA2 and FOXA2-DS-S in lung cancers (GSE18842 dataset). Tumour and normal individual samples are
represented as blue and red dots, respectively. Boxplots on the right show that both transcripts are down-regulated in tumour compared to
normal samples (Student’s t-test p values are indicated). c Invasion and migration assay analysis of Huh7 (left) and A549 (right) cells upon knock-
down of FOXA2-DS-S using two different siRNAs (si1 and si2) compared to negative control siRNA. The bars show the mean of three biological
replicate experiments. The error bars indicate the standard error of the mean. d Mutational analysis of CTCF and ZNF263 motifs associated with
tapRNA loci. CTCF and ZNF263 motifs inside of tapRNA loci have significantly higher chances to be mutated in cancer. In total, we catalogued
241 CTCF motif mutations in 171 motif sites (37 cancer types) and 196 ZNF263 motif mutations in 135 motif sites (27 cancer types). e Example of
a mutational analysis of CTCF and ZNF263 motifs associated within the ZEB2/ZEB2-AS/BT tapRNA locus, depicting the mutations found in melano-
mas. f Expression profile of ZEB2 and ZEB2-AS/BT in different cancers, showing concordant increased expression in malignancies, including skin
cutaneous melanoma (SKCM)
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Conserved domains and motifs within tapRNAs
Analysis of sequence conservation among tapRNAs has
shown that this group of RNAs is more conserved than
the bulk of lncRNAs. By direct alignment of human and
mouse tapRNAs, we observed stretches of high sequence
identity, which may reflect overlap of DNA regulatory re-
gions within tapRNA loci, but which is also consistent
with regions of ‘microhomology’ and of possible func-
tional conservation in lncRNAs [5, 17, 29, 82, 83]. Within
the conserved sequences of tapRNAs, ten degenerate mo-
tifs were found enriched. These motifs are similar to the
consensus binding sites of known RBPs, predominantly of
the CCCH zinc finger family. Although many of these are
likely involved in RNA processing, the enrichment in con-
served stretches of tapRNAs may also underscore a role in
tapRNA regulation and function. Interestingly, an analysis
of 58 diverse RBPs in human cells indicated that the ma-
jority of those RBPs also interact with chromatin in a
genome-wide fashion, including a large fraction of gene
promoters and regulatory sequences [84], suggesting the
occurrence of co-transcriptional deposition of RBPs on
target RNA substrates and a possible impact on genome
regulatory processes [4, 85, 86].
We noticed that the ten conserved motifs in tapRNAs also
correspond to consensus binding sites of transcription fac-
tors. Three of them are also enriched within enhancers on
the other end of the loop anchor point (Additional file 4:
Figure S13c). These three motifs all have the potential to
bind ZF proteins, including Zic2, which has been associated
with chromatin looping and enhancer function [87]. This
raises the possibility that the mechanism of action of ZF mo-
tifs within tapRNAs is related to the presence of similar ZF
motifs and DNA-bound proteins at enhancers. One mode of
action could be that tapRNA ZF motifs could induce the
sequestration or delivery of ZF factors to enhancers, for ex-
ample involving the formation of RNA–DNA hybrids or
triplex structures [88, 89]. In all these scenarios, the tapRNAs
could have an effect on the transcription of the associated
developmental coding gene by modulating the presence of
ZF transcription factors on enhancers. Binding of the YY1
transcription factor to RNA has recently been demon-
strated to play a role at enhancers [90], supporting the ar-
gument that RNA–transcription factor interactions may
influence enhancer activity. Finally, we also found evi-
dence that mouse tapRNAs are enriched in CLIP-Seq
peaks for CTCF [91] (Additional file 4: Figure S13d, e),
suggesting that regulation of CTCF binding may also be
possible, as indicated by previous work that identified
lncRNA binding of CTCF regulating chromatin looping
and expression of neighbouring genes [78, 92].
tapRNAs and cancer
Several lines of evidence presented here are consistent
with the role for tapRNAs in cancer development. Firstly,
a cancer microarray meta-analysis and the TGCA data
show that tapRNAs are misregulated in selected tumour
types. Second, we obtained a direct indication of their in-
volvement in cancer from the fact that manipulation of
their expression levels affects the phenotypic characteris-
tics of cancer cells in vitro, such as invasion and migra-
tion. Once again, the associated coding genes, which can
often be oncogenes or tumour suppressors, show a similar
effect on invasion and migration. For example, FOXA2 is
a tumour suppressor and inhibitor of EMT in human lung
cancers [57, 93] and reduced FOXA2 expression in hepa-
tocellular carcinoma (HCC) is associated with worse clin-
ical outcome. Here, our data also suggest the implication
of the tapRNA FOXA2-DS-S in this process, as well as
other tapRNAs affecting metastatic characteristics of dif-
ferent cancer cells (Additional file 4: Figure S15).
Another indication of the involvement of tapRNAs in
cancer comes from the finding that their promoters and/
or gene bodies are enriched in mutations linked to can-
cer. Mutations in the binding site for the zinc finger pro-
tein CTCF have already been described [58, 59], and we
find that tapRNAs overlap CTCF sites that are found
mutated in cancer. In addition, we identify a second zinc
finger protein (ZNF263) enriched in the conserved se-
quences of tapRNAs, which is also mutated in cancer
cells. Our analysis highlights the possibility that ZNF263
and potentially other zinc finger factors may play a role
in genomic organization, regulating genes that have crit-
ical roles in cancer.
Conclusions
In this study we have defined tapRNAs as a new subset
of lncRNAs with common structural and functional fea-
tures. Positional conservation was used as the original
criterion for this grouping, and a set of developmental
genes was identified as co-regulated with these RNAs.
This suggests the existence of an ‘extended gene struc-
ture’ where a small proportion of coding genes (3 %) are
connected genomically with long noncoding RNAs in a
functional unit. In addition, we found that in different
cases the protein-coding gene may regulate itself and
also the associated lncRNA, indicating the existence of
an intimate connection between these pairs and of posi-
tive feedback loops that may confer robust tissue-
specific expression. We expect this number of tapRNA–
gene pairs to be an underestimate given the stringent
criteria set for the current analysis. However the most
important and unexpected common feature of tapRNAs
is their genomic location at topological anchor points.
This genomic positioning and the enrichment of CTCF
motifs in the promoter and body of tapRNAs strongly
suggest a role for these RNAs in genomic organization.
The fact that tapRNAs overlap CTCF and ZNF263 mo-
tifs that are mutated in cancer also points to genomic
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organization as an important node in homeostasis and
disease. The involvement of tapRNAs in higher order
architectural organization may be particularly important
for the expression of developmental genes and for their
misregulation in cancer.
Methods
pcRNA cloning
Cloning of human full-length HNF1A-BT1 transcript was
performed using Gateway Technology (Thermo Fisher Sci-
entific, catalogue number 12535–019) according to the
manufacturer’s instructions. Briefly, 2 μg total RNA from
HepG2 cells were reverse transcribed in 20 μl reaction
using Superscript III Reverse Transcriptase (Invitrogen,
catalogue number 18080044). Touchdown-PCR was per-
formed using 2 μl of the cDNA, mixed with 38.75 μl water,
1 μl of each primer (10 μM) (Additional file 10: Table S8),
1.25 μl dNTP (10 mM), 5 μl 10× Pfu Ultra reaction buffer
and 1 μl Pfu Polymerase (Stratagene, catalogue number
600380). PCR was performed in the following conditions:
(i) 98 °C for 30 s, (ii) 98 °C for 10 s, (iii) 70–50 °C for 30 s,
(iv) 72 °C for 3 min (with 20 cycles repeating steps ii–iv,
thereby decreasing the temperature of step iii 1 °C per
cycle); followed by (v) 98 °C for 10 s, (vi) 50 °C for 30 s, (vii)
72 °C for 2 min, (viii) 72 °C for 5 min, with 15 cycles repeat-
ing steps v–vii. Nested PCR was performed with PCR
products after gel extraction and 1:100 dilution. The cyc-
ling conditions were: (i) 98 °C for 30 s, (ii) 98 °C for 10 s,
(iii) 59 °C for 30 s, (iv) 72 °C for 2 min, (v) 72 °C for 5
min, with 30 cycles repeating steps ii–iv. Gel purified PCR
products were quantified and transferred into the
pDONR221 entry vector (Life Technologies, catalogue
number 12536–017). Transformations were performed ac-
cording to the Gateway clonase protocol using Escherichia
coli DH5α and the plasmids used in an LR reaction to
generate the expression vectors using the LINC-EXPRESS
plasmid (modified pLENTI6.3/TO/V5-DEST, kindly pro-
vided by John Rinn [94]).
Cloning of shRNAs
Short hairpin (sh)RNA design was performed using the
Broad Institute RNAi Consortium software (http://
www.broadinstitute.org/rnai/public/seq/search), which
was used to select three or four different candidate
shRNAs per pcRNA. We tested their knockdown
efficiencies in transient transfections and the effective
shRNAs as well as negative control were used in
subsequent experiments (Additional file 10: Table S8).
Cloning of the annealed shRNA oligos into pLKO vec-
tors for shRNA constructs was performed as described
in the TRC Laboratory Protocol (version 2/12/2013).
Briefly, HPLC-purified oligomers were annealed using
final concentrations of 3 μM each in 1× NEB buffer 2
and used in ligations into pLKO vectors digested with
AgeI and EcoRI (pLKO.1 puro (addgene #8453) [95] and
Tet-pLKO-puro (addgene #21915) [96]. Ligation prod-
ucts were used for transformations of E. coli DH5α and
plasmids were purified and sequenced.
Cell culture
Cell lines (Additional file 10: Table S8) were acquired from
ATCC and cultured at 37 °C and 5 % CO2 in the recom-
mended media unless specified. Huh-7 and HepG2 cells
were grown in growth medium (Dulbecco’s modified Ea-
gle’s medium (DMEM), 10 % fetal bovine serum (FBS), 2
mM L-glutamine, 50 μg/ml penicillin and 50 μg/ml strepto-
mycin) at 37 °C and 5 % CO2. Human erythroleukemia
(K562) cells were cultured in RPMI 1640 media supple-
mented with 10 % FBS and 2 mM glutamine, and breast
adenocarcinoma (MCF7), lung adenocarcinoma (A549),
osteosarcoma (U2OS) and glioblastoma (U251MG) cells
were cultured in DMEM media supplemented with 10 %
FBS. Mouse embryonic stem cells (E14) were cultured in 1
% gelatin-coated dishes in DMEM media with 2 mM
glutamine, 1 mM sodium pyruvate, 1× non-essential
amino acids, 10 % FBS, 0.1 mM 2-mercaptoethanol, and
supplemented with 1000 U/mL LIF (ESGRO). Human
teratocarcinoma NT2/D1 cells were cultured in DMEM
supplemented with 10 % FBS. For induction of differenti-
ation, NT2 cells and mouse ES cells were cultured in
media without LIF and treated with 10 μM all-trans retin-
oic acid (Sigma R 2625) and harvested at different time
points.
Knock-down and over-expression
shRNA and siRNA oligonucleotides were ordered from
Thermo Fisher Scientific or as Qiagen FlexiTube siRNAs
(Additional file 10: Table S8). Transfections for siRNA-
mediated knock-down experiments were performed
according to the Lipofectamine RNAiMAX (Thermo
Fisher Scientific, catalogue number 13778150) proced-
ure. Briefly, the day before transfection 1 × 105 cells
were seeded in 2.5 ml DMEM/10 % FBS in six-well
plates. For each well, 50 nM siRNA duplexes were di-
luted in 250 μl Opti-MEM. Lipofectamine RNAiMAX (5
μl) was added to 245 μl Opti-MEM and combined with
the siRNA mix. After incubation for 10–20 min at room
temperature (RT) the mix was added dropwise to the
cells. Cells were incubated for 48 h until harvest. For
over-expression, the day before transfection 1 × 105 cells
per well were plated in six-well plates in 2 ml growth
medium without antibiotics. Transfections were per-
formed following the Fugene6 Transfection Reagent
Protocol (Promega, catalogue number E2691). Briefly,
185 μl of medium was premixed with 5 μl transfection
reagent per well in a six-well plate. After 5-min incuba-
tion at RT, 10 μl plasmid DNA (1 μg) were added to the
mix and incubated for 30 min at RT. Subsequently the
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transfection reagent–DNA mixture was added dropwise
to each well. The transfected cells were incubated for 48
h before processing.
RNA isolation and RT-PCR expression analysis
RNA from cell cultures was purified using Qiazol (Invitrogen)
and RNeasy Mini Kit (Qiagen) or Direct-zol RNA
MiniPrep kit (Zymo Research, catalogue number
R2072) and treated with DNase I (Invitrogen), accord-
ing to the manufacturers’ instructions. Purified tissue
RNA was purchased from Ambion (FirstChoice Hu-
man Total RNA Survey Panel, catalogue number
AM6000) and Clontech (Mouse Total RNA Master
Panel, catalogue number 636644) (Additional file 10:
Table S8). RNA quality was assessed using the 2100
Bioanalyzer (Agilent Technologies) prior to further
use. cDNA preparation and quantitative real-time
PCR (qPCR) analysis were performed as previously
described [20]. Each experiment was performed in at
least two biological replicates. Primers were designed
spanning splice sites in most cases and for
normalization of transcript expression levels, B2M,
ALAS1 or GAPDH primers were used (Additional file
10: Table S8).
Invasion-migration assays
We plated 2.5 × 104 cells in serum-free media in an in-
sert plate upper chamber with either non- or Matrigel-
coated membranes (24-well insert; pore size, 8 μm; BD
Biosciences, catalogue number 354578 and 354,480) for
trans-well migration and invasion assay, respectively.
The bottom chamber contained DMEM with 10 % FBS.
After 24 h, the bottom of the chamber insert was fixed
and stained with crystal violet and cells on the stained
membrane were counted under a microscope. Each
membrane was divided into four quadrants, and an aver-
age from all four quadrants was calculated. Each assay
was performed in biological triplicates.
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